Latest Neurogenesis Stories
ROCKVILLE, Md., Jan. 28, 2011 /PRNewswire/ -- Neuralstem, Inc. (Amex: CUR) announced that it has reach a settlement with ReNeuron, Ltd. ending litigation between the parties. The confidential settlement agreement resolves all claims asserted by Neuralstem against ReNeuron in Neuralstem, Inc. v.
For years, the majority of research on reactive oxygen species (ROS) â€“ ions or very small molecules that include free radicals â€“ has focused on how they damage cell structure and their potential link to stroke, cardiovascular disease and other illnesses.
ROCKVILLE, Md., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S.
Study might provide new clues to designing better treatments for depression and other neuropsychiatric disorders.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer.
Scientists have created a way to isolate neural stem cells â€“ cells that give rise to all the cell types of the brain â€“ from human brain tissue with unprecedented precision, an important step toward developing new treatments for conditions of the nervous system, like Parkinsonâ€™s and Huntingtonâ€™s diseases and spinal cord injury.
Chronic jet lag alters the brain in ways that cause memory and learning problems long after one's return to a regular 24-hour schedule.
Researchers from Georgetown University Medical Center's departments of neuroscience, pharmacology, physiology, biochemistry, molecular and cellular biology, and the interdisciplinary program of neuroscience will present more than 50 research abstracts at the 40th Annual Meeting of the Society for Neuroscience Nov. 13th through the 17th in San Diego.
ROCKVILLE, Md., Nov. 17, 2010 /PRNewswire-FirstCall/ -- Neuralstem, Inc.
Researchers at Duke-NUS Graduate Medical School in Singapore have uncovered a novel feedback mechanism that controls the delicate balance of brain stem cells.
- To give a box on the ear to.